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Background: The Middle East and North Africa (MENA) is postulated to have the highest increase in the prevalence
of diabetes by 2030; however, studies on the epidemiology of diabetes are rather limited across the region,
including in Iran.
Methods: This study was conducted between 2016 and 2018 among Iranian adults aged 20 to 65 years residing in
Khuzestan province, southwestern Iran. Diabetes was defined as the fasting blood glucose (FBG) level of 126 mg/dl
or higher, and/or taking antidiabetic medications, and/or self-declared diabetes. Prediabetes was defined as FBG
100 to 125 mg/dl. Multinomial logistic regression models were used to examine the association of multiple risk
factors that attained significance on the outcome.
Results: Overall, 30,498 participants were recruited; the mean (±SD) age was 41.6 (±11.9) years. The prevalence of
prediabetes and diabetes were 30.8 and 15.3%, respectively. We found a similar prevalence of diabetes in both
sexes, although it was higher among illiterates, urban residents, married people, and smokers. Participants aged 50–
65 and those with Body Mass Index (BMI) 30 kg/m2 or higher were more likely to be affected by diabetes [RR: 20.5
(18.1,23.3) and 3.2 (3.0,3.6)]. Hypertension [RR: 5.1 (4.7,5.5)], waist circumference (WC) equal or more than 90 cm [RR:
3.6 (3.3,3.9)], and family history [RR: 2.3 (2.2,2.5)] were also significantly associated with diabetes. For prediabetes, the
main risk factors were age 50 to 65 years [RR: 2.6 (2.4,2.8)], BMI 30 kg/m2 or higher [RR: 1.9 (1.8,2.0)], hypertension
and WC of 90 cm or higher [RR: 1.7 (1.6,1.8)]. The adjusted relative risks for all variables were higher in females than
males, with the exception of family history for both conditions and waist circumference for prediabetes.
© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: khamseh.m@iums.ac.ir; h.poustchi@gmail.com
†Sanam Hariri and Zahra Rahimi contributed equally to this work.
3Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran
University of Medical Sciences, Tehran, Iran
1Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases
Research Institute, Shariati Hospital, Tehran University of Medical Sciences, N.
Kargar St, Tehran, Iran
Full list of author information is available at the end of the article
Hariri et al. BMC Endocrine Disorders          (2021) 21:135 
https://doi.org/10.1186/s12902-021-00790-x
Conclusions: Prediabetes and diabetes are prevalent in southwestern Iran. The major determinants are older age,
obesity, and the presence of hypertension. Further interventions are required to escalate diabetes prevention and
diagnosis in high-risk areas across Iran.
Keywords: Diabetes, Prediabetes, Epidemiology, Risk-factors, Low and middle-income countries, Middle-east, Iran
Background
The Middle East and North Africa (MENA) region holds
the highest prevalence of diabetes mellitus (DM) world-
wide, and is estimated to have the most significant in-
crease in diabetes prevalence in the coming years [1].
However, there are limited population-based studies on
the epidemiology and determinants of diabetes in
MENA countries, including Iran [2].
By 2035, the number of adults with diabetes will in-
crease by 55% globally, and the greatest proportional
increase is expected in low-income, followed by low
to middle-income countries [3]. The MENA region is
estimated to have an over 95% increase in the num-
ber of people with diabetes by 2035 [4]. Nearly half
of all diabetes deaths in this region occur among
people under 60 years old; these premature deaths
may be due to the new emerging risk factors, delayed
diagnoses, and weak health-care systems that are not
competent to bear the growing burden [5]. In
addition, the absence of focused preventive measures,
as well as lack of sufficient health insurance coverage,
are among the major reasons underlying the high dia-
betes burden in MENA [6]. Aging populations, to-
gether with rapid urbanization that has brought major
behavioral and lifestyle changes in many countries in
this region, have resulted in a dramatic increase in
diabetes prevalence [7]. Identifying the main trad-
itional and non-traditional diabetes risk factors is cru-
cial for developing preventive strategies and early
diagnosis in such countries [2].
In Iran, the number of people with diabetes has been
projected to increase by 91%, and its economic burden
will increase markedly by 2035 [8, 9]. Despite the avail-
ability of medications and insulin coverage in Iran,
utilization of antidiabetic drugs and control of blood glu-
cose remains subpar [10–12]. According to previous na-
tional reports, only 13% of diabetes patients in Iran have
controlled hyperglycemia [12]. Another Iranian study
among patients living in urban areas reported that over
one-third have hemoglobin A1c (HbA1c) levels higher
than 9% [13]. In line with global initiatives to reduce the
diabetes burden, Iran has made great prevention efforts
in recent decades [14–16]. However, the rising trend of
diabetes is outpacing such efforts and current role of
diabetes risk factors remains poorly identified specially
in remote areas across Iran [2, 12]. The present study
aimed to investigate the prevalence and determinants of




The Khuzestan comprehensive health study (KCHS) was
conducted as a large cross-sectional study between Oc-
tober 2016 and November 2018 to assess the health con-
ditions of 30,500 Iranian adults. The study site was
Khuzestan province, located in southwestern Iran, which
covers an area of more than 63,000 km2 and is home to
a diverse population of nearly five million, including
Fars, Arab, Bakhtiari, Kurd, and Lur ethnic groups. Writ-
ten informed consent was obtained from all participants.
All procedures performed in the study were in accord-
ance with the ethical guidelines of the Declaration of
Helsinki and the ethics committee of the National Insti-
tute for Medical Research Development (NIMAD) has
approved the study protocol. The KCHS methodology
has been detailed elsewhere [17].
Study population
The study population includes all men and women aged
20 to 65 years, residing in urban and rural areas of Khu-
zestan province. The sample size required to estimate
the prevalence of any health conditions in the province
with 1% margin of error was calculated, and a 50% base-
line prevalence to maximize the required sample size
was assumed. Therefore, a sample size of 30,000 was
chosen, which will provide a power greater than 90%. To
obtain a representative sample, the population of all 27
counties in the province were stratified and a random
sample of primary care centers -called health houses- in
each county were chosen, which was proportional to
total province population living in that county. Ultim-
ately, 1079 random health houses were chosen and 30
individuals were randomly selected from the population
covered by each center. Inclusion criteria were having
been resided in Khuzestan for a minimum of 1 year
prior to the study enrolment. Exclusion criteria were un-
willingness to participate and any physical or psycho-
logical disability that hinder the participation.
Study procedures
A multistage random sampling method was used to se-
lect participants. Trained staff went door to door to ex-
plain the study goals and invite the participants to the
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pre-defined study sites on the next day. The study sites
include health centers, health houses, schools, and mos-
ques, located in the close proximity of participants’ resi-
dential address. All participants provided written
informed consent upon registration.
Fifteen mL of blood were obtained from each individ-
ual, divided into one clot tube and one EDTA tube.
Blood was transferred to the reference lab within three
hours of sampling, stored in Cool boxes at 4 °C. Blood
samples were centrifuged at 3000 rpm for 10min to sep-
arate serum; thereafter, serum level of fasting blood glu-
cose (FBG) was measured by BT 1500 AutoAnalyzer,
using commercial kits (Pars Azmoon, Iran). In case of
any abnormal laboratory results, participants were re-
ferred to family physicians for further evaluation.
To reduce the measurement error, anthropometric
data were gathered after blood sample collection, in a
fasting state for 8 to 12 h. Height and weight were mea-
sured by the Seca 206 body meter measuring tape with
Wall Stop and the Seca 762 mechanical flat scale, re-
spectively, and the Seca 203 circumference measuring
tape was used to measure waist circumference (WC).
Blood pressure was measured using aneroid sphygmo-
manometers (Riester, Germany), twice from each arm in
the sitting position. All measurements were in accord-
ance with the US National Institutes of Health protocols.
Data on demographics, socioeconomic status, and life-
style habits were collected afterward by staff-
administered questionnaires.
Definition of variables and study outcomes
Diabetes was defined as having an FBG level of 126mg/
dl or higher, and/or taking antidiabetic medications,
and/or self-declared diabetes. Prediabetes was defined as
the FBG level of 100 or higher, but equal to or less than
125 mg/dl. General obesity was determined based on
Body mass index (BMI), which is calculated by dividing
weight (kg) by the square of the height (m) and catego-
rized according to the World Health Organization
(WHO) cut-off points [18]. BMI scores less than 25 kg/
m2, between 25 and 29.9 kg/m2, and 30 kg/m2 or higher
were defined as normal weight, overweight, and obese,
respectively. Abdominal obesity was characterized by a
WC of 90 cm or higher for both men and women [19].
Following major guidelines, hypertension (HTN) was de-
fined as systolic blood pressure (SBP) equal to or higher
than 140 mmHg, and/or diastolic blood pressure (DBP)
equal to or higher than 90mmHg, and/or taking antihy-
pertensive medications [20]. Wealth score index was cal-
culated using multiple correspondence analysis (MCA)
with the following variables: house area, freezer, washing
machine, dishwasher, laptop, internet, car type, TV type,
indoor bathroom, vacuum cleaner, mobile use, and for-
eign travels [21].
Statistical analysis
Data are described by the mean and standard deviation
(SD) or frequency and percentage, where appropriate. A
multinomial logistic regression model was used to assess
the impact of the covariates on the risk of prediabetes or
diabetes, which led to relative risks (RR) as the measure
of association. In this model, individuals with prediabe-
tes and diabetes were compared with normal partici-
pants. Each of the covariates sex, age, BMI, WC, HTN,
family history of diabetes, and education have been put
in the model, once alone and once adjusted for cigarette
smoking (never/ever), hookah smoking (never/ever),
opium use (never/ever), alcohol use (never/ever), marital
status (single/married), residence (urban/rural), ethnicity
(Arab/Bakhtiari/Fars/Turk/Kurd/Lur), and wealth index
(four quartiles). These eight variables were selected as
the adjustments since the preliminary assessments
showed that the prevalence of prediabetes and diabetes
did not differentiate between these variables’ strata. Two
separate regression models were created to identify fac-
tors associated with prediabetes and diabetes in men and
women. The analyses were performed using the statis-
tical software Stata (version 12), and the chosen signifi-
cance level was 0.05.
Results
Overall, 30,498 individuals were included in the analysis,
of whom 19,600 (64.3%) were women. The mean age of
participants was 41.6 ± 11.9 years. The mean BMI and
WC were 27.6 ± 5.3 kg/m2 and 92.5 ± 13.4 cm, respect-
ively. Overall, the majority were married (83.0%), urban
residents (73.1%), of Arab ethnicity (49.0%), and had pri-
mary education (44.2%). Eighty-nine percent were never-
smokers, and cigarette smoking was reported among
28.0 and 1.3% of men and women, respectively. History
of hookah and opium use was reported among 5.2 and
2.8%, respectively. Family history of diabetes was re-
ported in 34.2% of all participants, and 19.7% were found
to have HTN.
Among all participants, 9395 (30.8%) were identified
to have prediabetes, and 4673 (15.3%) had diabetes. Dia-
betes had been self-reported among 2694 (57.7%) indi-
viduals, and 1941 (41.5%) had undiagnosed diabetes. The
highest prevalence of diabetes was observed among
people with HTN (33.5%), those who aged 50–65 years
(32.3%), illiterates (24.7%), and those with a family his-
tory of diabetes (22.6%). For prediabetes, the highest
prevalence was observed in people with BMI 30 kg/m2
or higher (34.6%), those with WC equal or more than
90 cm (33.2%), and the age range of 50–65 (32.9%) or
35–49.9 years (32.7%). Prevalence of diabetes was similar
in both sexes (15.3%), while prediabetes was slightly
higher in men (32.0 vs. 30.2%). Both conditions were
more prevalent among urban residents and marrieds.
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People who belonged to the highest wealth index cat-
egory and those of the Arab ethnicity had the highest
prevalence for both diabetes (16.3 and 16.8%) and predi-
abetes (32.2 and 33.3%), respectively (Table 1). The stan-
dardized prevalence that was calculated according to the
demographics, including sex, age, education, and BMI
strata, did not change compared to the unadjusted
prevalence of both conditions.
Results on multivariate analysis of the factors associ-
ated with diabetes and prediabetes risk are demonstrated
Table 1 Characteristics of the Khuzestan Comprehensive Health Study (KCHS) participants
Variable Normal Prediabetes Diabetes
Number 16,430 9395 4673
Sex Male 5750 (52.7%) 3483 (32.0%) 1665 (15.3%)
Female 10,680 (54.5%) 5912 (30.2%) 3008 (15.3%)
Age (years) 20–34.9 7154 (69.6%) 2766 (26.9%) 353 (3.5%)
35–49.9 6297 (53.9%) 3811 (32.7%) 1568 (13.4%)
50–65 2950 (34.8%) 2797 (32.9%) 2745 (32.3%)
BMI (Kg/m2) < 25 6343 (64.5%) 2593 (26.4%) 893 (9.1%)
25–29.9 5991 (52.4%) 3616 (31.6%) 1833 (16.0%)
≥30 4024 (44.3%) 3149 (34.6%) 1915 (21.1%)
Waist circumference (cm) < 90 8052 (64.9%) 3404 (27.4%) 949 (7.7%)
≥90 8306 (46.3%) 5955 (33.2%) 3692 (20.5%)
Hypertension No 14,333 (58.5%) 7501 (30.6%) 2659 (10.9%)
Yes 2089 (34.9%) 1891 (31.6%) 2013 (33.5%)
Diabetes family history No 11,531 (57.6%) 6180 (30.9%) 2314 (11.5%)
Yes 4867 (46.7%) 3201 (30.7%) 2350 (22.6%)
Education Illiterate 2996 (45.3%) 1981 (30.0%) 1629 (24.7%)
Elementary 7094 (52.6%) 4300 (31.9%) 2086 (15.5%)
Secondary 4696 (59.9%) 2340 (29.8%) 808 (10.3%)
Higher education 1642 (64.1%) 772 (30.1%) 149 (5.8%)
Cigarette smoking Never 14,560 (53.8%) 8401 (31.1%) 4085 (15.1%)
Ever 1784 (54.1%) 950 (28.8%) 564 (17.1%)
Hookah smoking Never 15,435 (53.7%) 8853 (30.8%) 4461 (15.5%)
Ever 909 (57.1%) 489 (30.7%) 195 (12.2%)
Opium use Never 15,871 (53.8%) 9119 (30.9%) 4515 (15.3%)
Ever 489 (57.5%) 229 (26.9%) 133 (15.6%)
Alcohol use Never 15,936 (53.7%) 9135 (30.8%) 4589 (15.5%)
Ever 406 (62.7%) 186 (28.7%) 56 (8.6%)
Marital status Single 3050 (58.9%) 1559 (30.1%) 569 (11.0%)
Married 13,380 (52.8%) 7836 (31.0%) 4104 (16.2%)
Ethnicity Arab 7454 (49.9%) 4971 (33.3%) 2501 (16.8%)
Bakhtiari 4236 (62.9%) 1668 (24.8%) 831 (12.3%)
Fars 2984 (53.1%) 1726 (30.7%) 911 (16.2%)
Turk/Kurd/Lur 1720 (54.6%) 1010 (32.0%) 422 (13.4%)
Residence Urban 11,605 (52.1%) 7001 (31.4%) 3678 (16.5%)
Rural 4824 (58.7%) 2394 (29.2%) 995 (12.1%)
Wealth index Q1 4239 (55.5%) 2271 (29.7%) 1131 (14.8%)
Q2 4018 (53.4%) 2340 (31.1%) 1161 (15.5%)
Q3 4435 (54.8%) 2457 (30.4%) 1197 (14.8%)
Q4 3641 (51.5%) 2274 (32.2%) 1152 (16.3%)
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in Table 2. For diabetes, the most significant risk fac-
tors include older age [RR (95% CI); 20.54 (18.13,
23.28)], HTN [RR (95%CI); 5.09 (4.72, 5.49)], and a
WC of 90 cm or higher [RR (95% CI); 3.62 (3.34,
3.92)]. Moreover, compared to the participants with a
BMI less than 25 kg/m2, those who had BMI 25–29.9
kg/m2 [RR (95% CI); 2.11 (1.93, 2.31)] or BMI equal
to or higher than 30 kg/m2 [RR (95% CI); 3.24 (2.96,
3.56)] were more likely to be affected by diabetes.
Having a history of diabetes in first-degree family
member was associated with a two-fold higher likeli-
hood of having diabetes [RR (95% CI); 2.30 (2.15,
2.46)], while higher education was associated with a
lower risk [RR (95% CI); 0.10 (0.09, 0.13)].
Regarding prediabetes, the most significant risk factors
were older age [RR (95% CI); 2.61 (2.43, 2.81)], BMI
equal to 30 kg/m2 or higher [RR (95% CI); 1.88 (1.76,
2.01)], HTN [RR (95%CI); 1.71 (1.60,1.83)], and a WC of
90 cm or more [RR (95% CI); 1.66 (1.58, 1.76)]. Similar
to diabetes, the highest educational degree was associ-
ated with a lower risk of prediabetes [RR (95% CI); 0.61
(0.54, 0.68)]. Furthermore, female sex was slightly pro-
tective against prediabetes [(RR (95% CI); 0.87 (0.82,
0.92)] (Table 2).
Results on multivariate analysis of the investigated fac-
tors stratified by gender are presented in Tables 3 and
4. We observed a statistically significant difference for
the association of diabetes and age among genders; the
relative risk was more than two-fold higher for women
with 50–65 years of age, compared to men in the same
age range [RR: 25.02 vs. 11.56].
Among women, HTN had a higher relative risk for dia-
betes [RR: 6.46 vs. 3.00] and prediabetes [RR: 1.91 vs. 1.37]
compared to men. Similarly, abdominal obesity in women
was more significantly associated with diabetes [RR: 3.90
vs. 2.85]. Women with abdominal and general obesity had
a similar likelihood of having diabetes [RR: 3.90 vs. 3.93],
while among men, abdominal obesity had a higher relative
risk for diabetes [RR: 2.85 vs. 2.47]. The relative risk for
diabetes family history was slightly higher among men
[RR: 2.49 vs. 2.25]. Regarding socioeconomic status,
women with higher education had a lower relative risk for
diabetes compared to men [RR: 0.03 vs. 0.27].
For prediabetes, the most significant risk factors were
older age and general obesity between both men [RR:
1.82 and 1.72] and women [RR: 3.01 and 2.04], respect-
ively, and older women had significantly higher relative











Female 0.91 (0.87, 0.96) 0.87 (0.82, 0.92) 0.97 (0.91, 1.04) 0.98 (0.91, 1.06)
Age (years) 20–34.9
35–49.9 1.57 (1.47, 1.66) 1.63 (1.53, 1.73) 5.05 (4.47, 5.69) 5.25 (4.63, 5.95)
50–65 2.45 (2.29, 2.62) 2.61 (2.43, 2.81) 18.86 (16.75, 21.24) 20.54 (18.13, 23.28)
BMI (Kg/m2) < 25
25–29.9 1.48 (1.39, 1.57) 1.47 (1.38, 1.56) 2.17 (1.99, 2.37) 2.11 (1.93, 2.31)
≥30 1.91 (1.79, 2.04) 1.88 (1.76, 2.01) 3.38 (3.09, 3.69) 3.24 (2.96, 3.56)
Waist circumference (cm) < 90
≥90 1.70 (1.61, 1.79) 1.66 (1.58, 1.76) 3.77 (3.49, 4.08) 3.62 (3.34, 3.92)
Hypertension No
Yes 1.73 (1.62, 1.85) 1.71 (1.60, 1.83) 5.19 (4.82, 5.59) 5.09 (4.72, 5.49)
Diabetes family history No
Yes 1.23 (1.16, 1.30) 1.17 (1.11, 1.24) 2.41 (2.25, 2.57) 2.30 (2.15, 2.46)
Education Illiterate
Elementary 0.92 (0.86, 0.98) 0.86 (0.80, 0.92) 0.54 (0.50, 0.58) 0.43 (0.40, 0.47)
Secondary 0.75 (0.70, 0.81) 0.67 (0.62, 0.73) 0.32 (0.29, 0.35) 0.21 (0.19, 0.24)
Higher education 0.71 (0.64, 0.79) 0.61 (0.54, 0.68) 0.17 (0.14, 0.20) 0.10 (0.09, 0.13)
*Data are adjusted for cigarette smoking (never vs. ever), hookah smoking (never vs. ever), opium use (never vs. ever), alcohol use (never vs. ever), marital status
(single vs. married), residence (urban vs. rural), ethnicity (Arab vs. Bakhtiari vs. Fars vs. Turk/Kurd/Lur), and wealth index (four quartiles)
*RR Relative risk
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35–49.9 1.64 (1.52, 1.76) 1.69 (1.56, 1.82) 5.62 (4.83, 6.54) 5.83 (4.99, 6.81)
50–65 2.85 (2.61, 3.10) 3.01 (2.75, 3.29) 23.2 (19.94, 26.99) 25.02 (21.42, 29.22)
BMI (Kg/m2) < 25
25–29.9 1.44 (1.32, 1.56) 1.47 (1.36, 1.60) 2.43 (2.16, 2.73) 2.47 (2.18, 2.79)




≥90 1.62 (1.52, 1.73) 1.63 (1.53, 1.74) 3.87 (3.51, 4.25) 3.90 (3.54, 4.31)
Hypertension No




Yes 1.22 (1.14, 1.30) 1.17 (1.09, 1.25) 2.31 (2.12, 2.51) 2.25 (2.07, 2.44)
Education Illiterate
Elementary 0.87 (0.80, 0.94) 0.82 (0.75, 0.89) 0.49 (0.45, 0.54) 0.41 (0.37, 0.45)
Secondary 0.66 (0.60, 0.73) 0.59 (0.53, 0.66) 0.23 (0.21, 0.27) 0.16 (0.14, 0.18)
Higher education 0.58 (0.51, 0.66) 0.49 (0.43, 0.57) 0.05 (0.03, 0.07) 0.03 (0.02, 0.05)
*Data are adjusted for cigarette smoking (never vs. ever), hookah smoking (never vs. ever), opium use (never vs. ever), alcohol use (never vs. ever), marital status
(single vs. married), residence (urban vs. rural), ethnicity (Arab vs. Bakhtiari vs. Fars vs. Turk/Kurd/Lur), and wealth index (four quartiles)
*RR Relative risk












35–49.9 1.44 (1.30, 1.59) 1.38 (1.23, 1.55) 4.13 (3.38, 5.03) 3.56 (2.85, 4.46)
50–65 1.92 (1.72, 2.14) 1.82 (1.61, 2.07) 13.42 (11.08, 16.27) 11.56 (9.24, 14.47)
BMI (Kg/m2) < 25
25–29.9 1.57 (1.42, 1.72) 1.46 (1.32, 1.61) 1.94 (1.71, 2.22) 1.66 (1.45, 1.90)




≥90 1.83 (1.68, 2.00) 1.66 (1.51, 1.82) 3.61 (3.16, 4.12) 2.85 (2.48, 3.27)
Hypertension No




Yes 1.28 (1.16, 1.40) 1.23 (1.12, 1.36) 2.65 (2.37, 2.97) 2.49 (2.21, 2.80)
Education Illiterate
Elementary 1.05 (0.92, 1.21) 0.97 (0.84, 1.12) 0.69 (0.59, 0.81) 0.55 (0.47, 0.65)
Secondary 0.94 (0.82, 1.08) 0.85 (0.73, 1.00) 0.50 (0.42, 0.59) 0.37 (0.31, 0.45)
Higher education 0.97 (0.81, 1.15) 0.84 (0.69, 1.02) 0.40 (0.32, 0.51) 0.27 (0.21, 0.36)
*Data are adjusted for cigarette smoking (never vs. ever), hookah smoking (never vs. ever), opium use (never vs. ever), alcohol use (never vs. ever), marital status
(single vs. married), residence (urban vs. rural), ethnicity (Arab vs. Bakhtiari vs. Fars vs. Turk/Kurd/Lur), and wealth index (four quartiles)
*RR Relative risk
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risk than men of the same age. No significant difference
was observed for the association of abdominal obesity
and prediabetes among both genders (Tables 3 and4).
We further evaluated the characteristics of the normal
weight and underweight participants affected by diabetes
(Table 5). Overall, 893 individuals with BMI less than 25 kg/
m2 were identified to have diabetes; the mean age was
50.4 ± 10.8 years and 50.2% were female. The mean WC in
this group was 86.1 ± 8.8 cm, mostly had a WC less than 90
cm (62.8%). The majority aged 50–65 years (61.1%), were
married (85.7%) and were urban residents (71.8%). Most of
these individuals had no history of HTN (64.3%) and smok-
ing (82.1%), while nearly half had a family history of diabetes
(48.1%) and one-third belonged to the lowest wealth index
category (29.9%). (Table 5).
Discussion
This study investigates the prevalence and determinants
of prediabetes and diabetes in a population-based sample
of Iranian adults residing in southwestern Iran. Predia-
betes with 30.8% and diabetes with 15.3% were more
prevalent in this area than in most other parts of the
country. In line with some previous Iranian studies,
older age, hypertension, and obesity were the most sig-
nificant risk factors for diabetes and prediabetes [22]
[23]. Also, family history of diabetes was associated with
Table 5 Characteristics of the Khuzestan study participants with diabetes who had Body Mass Index (BMI) less than 25 kg/m2
Variable Number (%)
People with diabetes and BMI < 25 kg/m2 893
Sex Male 445 (49.8%)
Female 448 (50.2%)
Age (years) 20–34.9 99 (11.1%)
35–49.9 248 (27.8%)
50–65 545 (61.1%)
Waist circumference (cm) < 90 561 (62.8%)
≥90 332 (37.2%)
Hypertension No 574 (64.3%)
Yes 319 (35.7%)
Diabetes family history No 463 (51.9%)
Yes 429 (48.1%)
Education Illiterate 309 (34.6%)
Elementary 396 (44.4%)
Secondary 161 (18.1%)
Higher education 26 (2.9%)
Cigarette smoking Never 725 (82.1%)
Ever 158 (17.9%)
Hookah smoking Never 843 (94.7%)
Ever 47 (5.3%)
Opium use Never 842 (94.7%)
Ever 47 (5.3%)
Alcohol use Never 869 (97.6%)
Ever 2 (2.4%)
Marital Status Single 127 (14.3%)
Married 760 (85.7%)
Residence Urban 637 (71.8%)
Rural 250 (28.2%)
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a two-fold higher risk of diabetes. These findings indi-
cate that urgent control measures are needed to impede
the high burden of diabetes in this region of Iran.
The prevalence of diabetes in this study was identical
to a survey conducted by Yazdanpanah et al. in 2015,
which is the only available report on diabetes from
southwestern Iran (15.3% vs. 15.1%) [24], and was com-
parable to two recent studies from central (16.1%) [25]
and Northern Iran (17.2%) [9]. However, this prevalence
was nearly two-fold higher compared to the national es-
timations [26] and other parts of the country, including
western [27], southeastern [28], and southern areas [29].
For prediabetes, two population-based studies in central
and southeastern Iran have reported a lower prevalence
(26 and 19%); however, in both studies, individuals
under the age of 35 years were also recruited [25]. These
comparisons indicate that diabetes is exceptionally
prevalent in the southwestern region of Iran, and urgent
interventions should be taken to scale-up focused pre-
ventive and diagnostic programs [15]. Also, people of
Arab ethnicity had the highest prevalence of both condi-
tions. Given the subpar control of hyperglycemia in Iran,
therapeutic interventions should be particularly ex-
panded into the most high-risk populations and ethnic
groups [12].
Globally, elderly people are at substantial risk for dia-
betes [30]. In this study, one-third of individuals aged
50–65 years had diabetes, which is similar to the results
of an elderly-based survey conducted among people
above 60 years in southern Iran; however, their reported
prevalence for prediabetes was two-fold higher than our
estimation for elderlies (67% vs. 33%) [31]. Although
older age was also the most significant risk factor for
prediabetes, its relative risk was much lower compared
to diabetes (2.4 vs. 18.5). Besides, older women had
more than two-fold higher the relative risk of diabetes
than men across the age range (25.0 vs. 11.6), which can
be explained by the large sex differences in obesity rates,
especially after the age of 45 years and in countries with
greater gender inequality [32, 33].
The second significant diabetes risk factor was HTN,
having a five-fold higher relative risk in people with
HTN than those without such condition, and a two-fold
higher relative risk for women compared to men. This
observation is in line with previous global reports [34].
Regarding obesity, some studies have emphasized the
benefits of WC compared to BMI in predicting diabetes
in the Iranian population [1, 35]. In our study, WC
showed a stronger association than BMI for diabetes (3.6
vs. 3.2), but not for prediabetes (1.7 vs. 1.9). Existing evi-
dence has shown that men are diagnosed with diabetes
at lower BMI than women of the same age group [36].
Accordingly, we observed no difference between WC
and BMI among women for the risk of diabetes; how-
ever, BMI had a lower relative risk in men.
A study from Northern Iran showed that having one
or more than one family member with diabetes increases
the odds of this disease to 2.3 and 4.2, respectively [9].
Another cohort from the center of Iran showed that
people with a first-degree family history were 3.3 times
more likely to have the disease [37]. Similarly, family his-
tory in first-degree relatives, having a relative risk equal
to 2.4, was among the significant risk factors for diabetes
in our study, with a slightly higher relative risk in men.
Also, from people with diabetes and normal BMI, ap-
proximately half had a family history of diabetes, and the
majority were from the lower socioeconomic categories.
In a study conducted on over 9000 Iranian adults, Mir-
zaei et al. have found a negative interaction between
family history of diabetes and other risk factors only for
BMI [38]. Their results suggested that despite consider-
ing family history as an independent risk factor, as long
as it is used as a tool to raise awareness and promote
lifestyle changes, it would reduce the risk of developing
diabetes in people with other risk factors such as
obesity.
Evidence on the modifying effect of sex in the de-
velopment of diabetes is controversial. Several Iranian
studies have reported a higher prevalence among fe-
males [1, 39, 40], and some others have not found
any significant associations for sex [41]. Similar to the
study of Yazdanpanah et al. from southwestern Iran,
we observed a similar prevalence of diabetes in both
sexes. Moreover, in our study, the female sex was
slightly protective against prediabetes. According to a
recent study, obesity is the most significant risk factor
for sex inequalities in type 2 diabetes in Iranians and
can partly explain the observed differences in the
prevalence of diabetes between sexes [42].
Many studies have confirmed the role of socioeco-
nomic factors in developing diabetes [43]. We observed
higher diabetes and prediabetes prevalence among urban
residents and illiterates. In fact, any level of education,
mostly higher education, appears to be a protective fac-
tor for both diabetes and prediabetes. We also observed
that higher education is more protective for diabetes
among women, compared to men. In total, 8.4% of par-
ticipants have had higher education, while only 2.9% of
participants with diabetes and BMI < 25 reported higher
education. This observation suggests that lower educa-
tion has bidirectional effects, both on its association with
BMI < 25, and with higher prevalence of diabetes. These
findings were in line with other studies on socioeco-
nomic inequalities and diabetes in Iran [25, 44].
Although many studies indicate that smoking increases
the risk of diabetes, some evidence supports the reverse
association [45]. In our study, diabetes was more
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prevalent in ever-smokers, while for prediabetes a higher
prevalence was observed among never-smokers. Also,
studies have suggested that opium may temporarily de-
crease blood glucose [46]. Among people who had a his-
tory of opium use in the present study, the prevalence of
prediabetes was slightly higher compared to those who
had never used; however, for diabetes the prevalence
was similar among both groups. Therefore, the associ-
ation of cigarette and opium use with diabetes in the
Iranian population needs further investigation.
Limitations
In this study, people above the age of 65 years were
not included, which may have been led to a lower es-
timation of diabetes prevalence. Besides, using only
one method for diagnosis and the unavailability of
oral glucose tolerance test (OGTT) and HbA1c test-
ing might be other causes of underestimating the
prevalence of diabetes in this region of Iran. However,
in many epidemiological studies in the region, there
is significant discordance between OGTT and FBG-
based prediabetes and diabetes diagnoses, and the
prevalence of newly diagnosed diabetes is about 15 to
20% higher according to the FBG criteria [47]. The
cross-sectional design and higher participation rate
among women and housewives were among the other
limitations of this study. Also, we were unable to ex-
clude Type 1 diabetes from our analysis.
Conclusions
Prediabetes and diabetes are prevalent in southwestern
Iran, and their prevalence is higher than in most parts of
the country. The major determinants are older age, the
presence of hypertension, and obesity. Further studies
are needed to better understand the epidemiology of dia-
betes across Iran, and urgent interventions should be ap-
plied to escalate diabetes prevention, diagnosis, and
treatment among high-risk populations residing in Iran.
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